New Zealand markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
152.33+2.02 (+1.34%)
At close: 04:00PM EDT
146.74 -5.59 (-3.67%)
After hours: 04:34PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts21212221
Avg. Estimate-1.06-1.05-3.95-1.75
Low estimate-1.57-1.56-5.8-4.32
High estimate-0.09-0.22-0.961.36
Year ago EPS-2.211.15-3.52-3.95
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts21212724
Avg. Estimate457.83M463.17M1.86B2.32B
Low estimate418.2M439.1M1.8B1.88B
High estimate565.06M495.5M2.04B2.97B
Year ago sales318.75M750.53M1.83B1.86B
Sales growth (year/est)43.60%-38.30%1.90%24.30%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.37-1.34-1.32-1.18
Actual EPS-2.211.15-1.1-0.52
Difference-0.842.490.220.66
Surprise %-61.30%185.80%16.70%55.90%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.06-1.05-3.95-1.75
7 days ago-1.04-1.1-4.11-1.76
30 days ago-1.04-1.1-4.18-1.76
60 days ago-1.03-1.1-4.18-1.77
90 days ago-1.21-1.32-4.2-1.04
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1474
Up last 30 days1485
Down last 7 daysN/AN/AN/AN/A
Down last 30 days32N/A4
Growth estimatesALNYIndustrySector(s)S&P 500
Current qtr.52.00%N/AN/AN/A
Next qtr.-191.30%N/AN/AN/A
Current year-12.20%N/AN/AN/A
Next year55.70%N/AN/AN/A
Next 5 years (per annum)-177.50%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A